Results 161 to 170 of about 67,212 (289)

Macrophage Phenotype Alterations in Treated Periodontitis Patients Suggest a Pro‐Inflammatory Bias

Journal of Periodontal Research, EarlyView.
Monocyte‐derived macrophages from successfully treated stage III periodontitis patients show a persistent skewing toward an M1‐like pro‐inflammatory phenotype across polarization conditions, suggesting that immune dysregulation may persist despite clinical periodontal stability.
Mariane Cristina Sloniak, Josiane Betim de Assis, Luciana Saraiva, Cláudio Mendes Pannuti, Ana Paula Lepique, Cristina Cunha Villar   +5 more
wiley   +1 more source

Non-union after bisphosphonate-associated atypical femoral fractures: a review of the current literature. [PDF]

Eur J Orthop Surg Traumatol
Dowling J, Marsh S, O'Grady J.
europepmc   +1 more source

Idiopathic osteonecrosis of the mandible in a 49 healthy male patient: a rare and interesting case report [PDF]

, 2019
Campisi, Giuseppina, Canepa, Federica, Di Fede, Olga, Dioguardi, Mario, Mauceri, Rodolfo, Panzarella, Vera   +5 more
core   +1 more source

Radiographic Analysis of MRONJ in Osteoporotic and Oncologic Patients on Bisphosphonates or Denosumab

Oral Diseases, EarlyView.
ABSTRACT Introduction Medication‐Related Osteonecrosis of the Jaw (MRONJ) is a severe adverse effect of antiresorptive and antiangiogenic treatment, primarily in osteoporotic and oncologic patients. The disease is characterized by persistent jawbone necrosis that results in significant impairment of the quality of life of involved patients.
Omar Ghanaiem, Gavriel Chaushu, Daya Masri   +2 more
wiley   +1 more source

Gorham-Stout disease with thoracic involvement: pathogenic mechanisms, respiratory complications, and multimodal therapies. [PDF]

Orphanet J Rare Dis
Li N, Le X, Xu D, Chen T, Zeng Y, Wang J.   +5 more
europepmc   +1 more source

MRONJ Risk Related to Dental Implants in Osteoporosis Treated With Denosumab: A Systematic Review

Oral Diseases, EarlyView.
ABSTRACT Objectives The aim of this systematic review was to assess the impact of dental implants in osteoporotic patients undergoing treatment with denosumab on MRONJ development, considering both implant surgery‐triggered osteonecrosis (ISTO) and implant presence‐triggered osteonecrosis (IPTO).
Rebheca Maria Pereira Santos, Giulia Ottaviani, Roberto Di Lenarda, Matteo Biasotto, Katia Rupel   +4 more
wiley   +1 more source

Zoledronic acid for chronic kidney disease-associated osteoporosis. [PDF]

Arch Osteoporos
Sakthivel S, Kjærgaard KD, Ivarsen P, Langdahl B, Jørgensen HS.   +4 more
europepmc   +1 more source

Bisphosphonates [PDF]

Dental Press Implantology, 2015
openaire   +1 more source

Is Fluorescence‐Guided Surgery Reliable for the Treatment of MRONJ? A Systematic Review and Meta‐Analysis

Oral Diseases, EarlyView.
ABSTRACT Background Identification of healthy bone margins is a critical step in the surgical resective treatment of medication‐related osteonecrosis of the jaw (MRONJ). Fluorescence‐guided surgery (FGS) has been proposed as a method to identify resection margins and improve clinical outcomes.
Paolo De Angelis, Alessandro Donato Tescione, Ivan Michele Aniceto, Cosimo Rupe, Gioele Gioco, Romeo Patini, Carlo Lajolo   +6 more
wiley   +1 more source

Novel use of bisphosphonates to improve surgical outcomes in experimental bone tuberculosis. [PDF]

World J Orthop
Petukhova VV, Mushkin AY, Maletin AS, Dogonadze MZ, Zabolotnykh NV, Dyakova ME, Esmedlyaeva DS, Vinogradova TI, Kostik MM.   +8 more
europepmc   +1 more source